<DOC>
	<DOCNO>NCT02554240</DOCNO>
	<brief_summary>This Phase II clinical study evaluate efficacy safety DA-5202 patient osteoarthritis knee .</brief_summary>
	<brief_title>Study Evaluate Efficacy Safety Intra-articular DA-5202 Patients With Osteoarthritis Knee</brief_title>
	<detailed_description>Eligible subject randomly assign receive DA-5202 high dose ( 20mg ) DA-5202 low dose ( 10mg ) Na Hyaluronate week intra-articular injection 3 week .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<criteria>male female patient 20 80 old primary knee osteoarthritis confirm clinically radiologically accord American College Rheumatology criterion follow 3 item 1. knee joint pain 2. follow 1. male females 50 2. morning stiffness within 30 minute 3. crepitus 3. presence spur radiological evidence KellgrenLawrence Grade Ⅰ Ⅲ confirm radiologically knee pain weightbearing great 40/100mmVAS ( Visual Analogue Scale ) randomization visit patient willing able provide sign informed consent nature study explain BMI ( Body Mass Index ) &gt; 32 complete obliteration femoropatellar joint space Xray KellgrenLawrence Grade IV knee surgery within year history fracture , rheumatoid arthritis inflammatory arthritis knee articular cavity intraarticular corticosteroid injection within 3 month hyaluronate injection within 6 month skin disease infection overlie joint history severe drug allergy hypersensitivity drug ( piroxicam , hyaluronic acid ) history allergy , asthma , rhinitis , angioedema , rash aspirin NSAIDs ( include COX2 inhibitor ) treatment anticoagulant heparin coumarins ( warfarin etc . ) History GI diseases peptic ulcer , bleeding , perforation , ulcerative colitis , Crohn 's disease within 1 year severe hypertension patient psychiatric disorder , alcoholism , drug addiction presence severe concomitant disease malignancy within 5 year participate another clinical trial 4 week prior study woman childbearing potential use *adequate mean contraception ( *adequate mean contraception : condom , oral contraception , barrier method use spermicide , intrauterine device etc . ) condition , view investigator , would interfere study participation</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>